Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Samonigg

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Oncology|November 20, 2001
Prognostic relevance of three histological grading methods in breast cancerL Latinovic, G Heinze, P Birner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II studyH Samonigg, A K Kasparek, H Stöger, et al.
British Journal of Cancer|July 4, 2013
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsG Absenger, J Szkandera, M Pichler, et al.
American Journal of Clinical Oncology|January 1, 1990
Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results)H Samonigg, H Stöger, T Bauernhofer, et al.
Clinical Immunology and Immunopathology|December 1, 1992
Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibodyH Samonigg, M Wilders-Truschnig, H Loibner, et al.
Wiener Klinische Wochenschrift|January 1, 1992
Surgical and non-surgical treatment of cancer of the oesophagus and the oesophagogastric junction: results of 200 consecutive casesF M Smolle-Juettner, H Pinter, J Smolle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patientsH Stöger, T Bauernhofer, M Schmid, et al.
The British Journal of Dermatology|January 25, 2008
In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour imagesA Gerger, R Hofmann-Wellenhof, U Langsenlehner, et al.
British Journal of Cancer|September 13, 2012
Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survivalT Gary, K Belaj, K Steidl, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III studyH Hausmaninger, R Moser, H Samonigg, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Oncology|November 20, 2001
Prognostic relevance of three histological grading methods in breast cancerL Latinovic, G Heinze, P Birner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II studyH Samonigg, A K Kasparek, H Stöger, et al.
British Journal of Cancer|July 4, 2013
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsG Absenger, J Szkandera, M Pichler, et al.
American Journal of Clinical Oncology|January 1, 1990
Combination therapy of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose folinic acid in patients with advanced breast cancer: a phase I-II study (preliminary results)H Samonigg, H Stöger, T Bauernhofer, et al.
Clinical Immunology and Immunopathology|December 1, 1992
Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibodyH Samonigg, M Wilders-Truschnig, H Loibner, et al.
Wiener Klinische Wochenschrift|January 1, 1992
Surgical and non-surgical treatment of cancer of the oesophagus and the oesophagogastric junction: results of 200 consecutive casesF M Smolle-Juettner, H Pinter, J Smolle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patientsH Stöger, T Bauernhofer, M Schmid, et al.
The British Journal of Dermatology|January 25, 2008
In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour imagesA Gerger, R Hofmann-Wellenhof, U Langsenlehner, et al.
British Journal of Cancer|September 13, 2012
Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survivalT Gary, K Belaj, K Steidl, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III studyH Hausmaninger, R Moser, H Samonigg, et al.
Pageof 8